CXCL9, CXCL10, and CXCL1 represent the most promising chemokine biomarkers due to high diagnostic performance (AUC = 0.84–1.00) and precise differentiation of drug-sensitive/resistant TB and latent Infection. This evidence concerns the gene CXCL1 and tuberculosis.